The Federation of American Societies for Experimental Biology (FASEB) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. Category I Continuing Medical Education (CME) credits will be offered at this meeting. For the purpose of Continuing Medical Education credits toward the American Medical Association Physician's Recognition Award, the EB 2005 meeting is jointly sponsored by FASEB.

CME a pplication forms are available from the Experimental Biology 2005 Meeting Office, 9650 Rockville Pike, Bethesda, MD, 20814-3998, 301-634-7010; email: eb@faseb.org or through any of the society offices. There is a $45 application fee, payable upon submission of the form.

Meeting Objective/Target Audience

At the completion of this meeting, participants should be able to: 1) discuss the research underway and/or the current topics relevant to their areas of interest in pharmacology, immunology, anatomy, physiology, biochemistry and molecular biology, pathology, and nutrition; 2) demonstrate a gained level of insight into the methods being used by researchers and practitioners in these fields; and 3) describe a personal exposure to several stimulating areas of inquiry with speakers in related areas. Preliminary programs for the participating societies are available on the EB 2005 home page . This meeting is targeted to clinical practitioners, research scientists, and medical education professionals.

Disclosure Policy

The Federation requires that audiences at FASEB-sponsored educational programs be informed of a presenter's (speaker, faculty, author, or contributor) academic and professional affiliation, and the existence of any significant financial interest or other relationship a presenter has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during the presentation, it is required that presenter’s disclose that the product is not labeled for the use under discussion or that the product is still investigational.

This policy allows the listener/attendee to be fully knowledgeable in evaluating the information being presented. The Program will note those speakers who have disclosed relationships, including the nature of the relationship and the associated commercial entity.

Disclosure should include any relationship that may bias one's presentation or which, if known, could give the perception of bias. These situations may include, but are not limited to: 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) research grants; 3) employment (full or part-time); 4) ownership or partnership; 5) consulting fees or other remuneration; 6) non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson; 7) receipt of royalties; 8) speaker’s bureau; 9) other. For full- time employees of industry or government, the affiliation listed in the Program will constitute full disclosure.

Return to the EB2005/IUPS Meeting homepage